See the DrugPatentWatch profile for lyrica
After reviewing the available information, I found that the reason for stopping Lyrica (pregabalin) is not explicitly stated. However, there are a few potential reasons that have been suggested.
Firstly, Lyrica is a medication used to treat various conditions such as epilepsy, neuropathic pain, and generalized anxiety disorder [1]. However, like all medications, it can have side effects, and some of these can be serious. For example, Lyrica can cause dizziness, drowsiness, and difficulty concentrating, which can impact a person's ability to drive or operate machinery safely [1]. Additionally, Lyrica has been associated with an increased risk of suicidal thoughts and behavior, particularly in people with a history of mental health issues [1].
Another potential reason for stopping Lyrica is its potential for abuse and dependence. Lyrica, like other gabapentinoids, has been linked to cases of misuse, abuse, and dependence [2]. In some cases, people have taken Lyrica in higher doses or more frequently than prescribed, or have taken it without a prescription [2]. This can lead to serious health consequences, including overdose and death [2].
It's important to note that the decision to stop taking Lyrica should be made in consultation with a healthcare provider. Suddenly stopping Lyrica can lead to withdrawal symptoms, including anxiety, nausea, and insomnia [1]. A healthcare provider can provide guidance on how to safely taper off the medication, if appropriate.
In summary, while the specific reason for stopping Lyrica is not provided in the available information, potential reasons include side effects, the potential for abuse and dependence, and the need for a gradual tapering off of the medication.
Sources:
[1] "Pregabalin." MedlinePlus, U.S. National Library of Medicine, 22 Feb. 2022, medlineplus.gov/druginfo/meds/a605004.html.
[2] "Gabapentinoids: A Review of Newer Anticonvulsants." American Journal of Health-System Pharmacy, vol. 72, no. 16, 2015, pp. 1324-1334., doi:10.2146/ajhp140681.
Additional sources:
[3] "Pregabalin (Lyrica)." DrugPatentWatch, drugpatentwatch.com/pregabalin.